| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 106.69B | 100.80B | 103.15B | 110.25B | 93.18B | 87.19B |
| Gross Profit | 17.73B | 15.41B | 17.35B | 16.56B | 11.39B | 12.33B |
| EBITDA | 9.93B | 7.66B | 10.09B | 10.19B | 5.63B | 6.38B |
| Net Income | 3.96B | 2.35B | 3.82B | 4.13B | 1.49B | 2.44B |
Balance Sheet | ||||||
| Total Assets | 98.40B | 97.39B | 95.23B | 99.23B | 85.75B | 78.22B |
| Cash, Cash Equivalents and Short-Term Investments | 23.81B | 20.14B | 16.83B | 20.68B | 14.76B | 14.88B |
| Total Debt | 17.61B | 17.56B | 13.92B | 16.04B | 11.50B | 10.82B |
| Total Liabilities | 48.04B | 48.08B | 46.11B | 54.06B | 44.87B | 39.02B |
| Stockholders Equity | 47.04B | 45.73B | 44.97B | 41.29B | 37.28B | 36.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.82B | -1.00M | 2.74B | 1.10B | 4.46B |
| Operating Cash Flow | 0.00 | 4.67B | 4.24B | 7.55B | 3.63B | 7.30B |
| Investing Cash Flow | 0.00 | -2.40B | -3.95B | -4.89B | -2.66B | -4.55B |
| Financing Cash Flow | 0.00 | 1.11B | -3.96B | 2.95B | -1.13B | -155.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥58.28B | 10.11 | ― | 3.25% | 9.50% | 77.72% | |
77 Outperform | ¥22.54B | 9.09 | ― | 3.07% | 13.22% | 28.90% | |
74 Outperform | ¥15.42B | 15.28 | ― | 3.21% | 5.83% | -16.54% | |
69 Neutral | ¥12.95B | 55.69 | ― | 1.24% | -2.82% | -44.93% | |
67 Neutral | ¥499.39B | 21.99 | 7.93% | 2.32% | -2.26% | -10.86% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
49 Neutral | ¥20.09B | -133.31 | ― | 3.24% | -3.73% | -143.19% |